Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Billion Medical Publishing Market Report 2021: Medical Journals Show Stability Through COVID-19 Pandemic


DUBLIN, Sept. 21, 2021 /PRNewswire/ -- The "Global Medical Publishing 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Medical publishing is a $10 billion industry whose market leaders enjoy double-digit profit margins, serving one of the fastest-growing sectors of the economy. Medical publishing has a diverse set of revenue channels. In this report, the overall market and each market segment are divided into five content delivery channels: books, journals, online content, abstracting and indexing, and other activities.

Global Medical Publishing 2021-2025 contains separate chapters covering the market, key competitors, and trends and forecast that include:

Global Medical Publishing 2021-2025 provides the intelligence to evaluate growth potential, understand trends affecting the industry, and size up the competition in the dynamic markets for STM content worldwide. Examples of some of the trends covered include:

Global Medical Publishing 2021-2025 is an essential tool for publishing executives, M&A advisors, market analysts and industry consultants who need to understand the business strategies driving the medical publishing industry.


Key Topics Covered:

METHODOLOGY

DEFINITION OF MEDICAL PUBLISHING

CHAPTER 1: GLOBAL MEDICAL PUBLISHING MARKET

CHAPTER 2: LEADING MEDICAL PUBLISHERS

CHAPTER 3: TRENDS & FORECAST

For more information about this report visit https://www.researchandmarkets.com/r/y7oenl

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...



News published on and distributed by: